Levothyroxine sodium (Xeris Pharmaceuticals)
左旋甲状腺素皮下注射制剂 （Xeris Pharmaceuticals）
Report date: 2025/10/24 16:19:05
Base Information
Drug NameLevothyroxine sodium (Xeris Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXeris Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesXeris Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A